Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Kymera Therapeutics, Inc. | 247,588 | reported | 18 May 2026 | tx 86+1,110,374−505,250 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 May 2026 | EXERCISE | Kymera Therapeutics, Inc. | 15,000 | 2.08 USD | |
| 18 May 2026 | EXERCISE | Kymera Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 04 Mar 2026 | SALE | Kymera Therapeutics, Inc. | 1,437 | 85.78 USD | |
| 04 Mar 2026 | SALE | Kymera Therapeutics, Inc. | 492 | 84.00 USD | |
| 02 Mar 2026 | GRANT_AWARD | Kymera Therapeutics, Inc. | 17,650 | 0.00 USD | |
| 02 Mar 2026 | SALE | Kymera Therapeutics, Inc. | 2,039 | 87.75 USD | |
| 02 Mar 2026 | SALE | Kymera Therapeutics, Inc. | 1,424 | 88.50 USD | |
| 04 Mar 2026 | SALE | Kymera Therapeutics, Inc. | 447 | 86.62 USD | |
| 02 Mar 2026 | SALE | Kymera Therapeutics, Inc. | 4,113 | 89.66 USD | |
| 04 Mar 2026 | SALE | Kymera Therapeutics, Inc. | 2,519 | 85.04 USD | |
| 02 Mar 2026 | GRANT_AWARD | Kymera Therapeutics, Inc. | 35,300 | 0.00 USD | deriv |
| 17 Sept 2025 | EXERCISE | Kymera Therapeutics, Inc. | 79,220 | 2.08 USD | |
| 17 Sept 2025 | SALE | Kymera Therapeutics, Inc. | 79,220 | 50.00 USD | |
| 17 Sept 2025 | EXERCISE | Kymera Therapeutics, Inc. | 36,974 | 0.00 USD | deriv |
| 17 Sept 2025 | EXERCISE | Kymera Therapeutics, Inc. | 42,246 | 0.00 USD | deriv |
| 31 Mar 2025 | EXERCISE | Kymera Therapeutics, Inc. | 25,000 | 2.08 USD | |
| 31 Mar 2025 | EXERCISE | Kymera Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 03 Mar 2025 | GRANT_AWARD | Kymera Therapeutics, Inc. | 30,000 | 0.00 USD | |
| 03 Mar 2025 | SALE | Kymera Therapeutics, Inc. | 5,754 | 30.33 USD | |
| 03 Mar 2025 | SALE | Kymera Therapeutics, Inc. | 1,281 | 31.00 USD | |
| 03 Mar 2025 | GRANT_AWARD | Kymera Therapeutics, Inc. | 60,000 | 0.00 USD | deriv |
| 10 Jan 2025 | EXERCISE | Kymera Therapeutics, Inc. | 10,000 | 2.08 USD | |
| 10 Jan 2025 | EXERCISE | Kymera Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 27 Jun 2024 | EXERCISE | Kymera Therapeutics, Inc. | 25,000 | 2.08 USD | |
| 27 Jun 2024 | EXERCISE | Kymera Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |